Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Dendreon's CEO Discusses Q2 2012 Results - Earnings Call TranscriptTue, Jul 31, 2012 • 1 Comment
-
Dendreon's CEO Discusses Q1 2012 Results - Earnings Call TranscriptMon, May 7, 2012 • 12 Comments
-
Dendreon's CEO Discusses Q4 2011 Results - Earnings Conference CallMon, Feb 27, 2012 • 10 Comments
-
Dendreon CEO Discusses Q3 2011 Results - Earnings Call TranscriptWed, Nov 2, 2011 • 2 Comments
-
Dendreon Corporation Q2 2008 Earnings Call TranscriptWed, Sep 3, 2008
-
Dendreon Corporation Q4 2007 Earnings Call TranscriptMon, Mar 31, 2008
-
Business Wire (May 31, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Mar 18, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 25, 2013)
-
at MarketWatch.com (Jan 11, 2013)
-
at CNBC.com (Jan 11, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Dec 20, 2012)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 14, 2012)
-
Business Wire (Nov 2, 2012)
-
at CNBC.com (Oct 29, 2012)
-
Business Wire (Oct 29, 2012)
-
Business Wire (Oct 3, 2012)
DNDN vs. ETF Alternatives
Company Description
Dendreon Corporation (“Dendreon”, the “Company”, “we”, “us”, or “our”), is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients. Our product portfolio includes active... More
